INTRODUCTION
Vitamin D is known to be biologically inactive and converted into 1,25 dihydroxy vitamin D by hydroxylation in the kidney and liver. The most important factors in renal regulation of Vitamin D synthesis are PTH and phosphorus levels (1, 2) . According to the KDOQI guidelines, if 25(OH)D3 level in the circulation is lower than 5 ng/ml, then it is considered as severe vitamin D deficiency; if it is between 5-15 ng/ml, it is considered as mild vitamin D deficiency; if it is between 15-29 ng/ml, it is considered as vitamin D deficiency; if it is higher than 30 ng/ml, it is considered as normal vitamin D level; if it is more than 150 ng/ml, it is considered as vitamin D intoxication. If 25(OH)D3 levels are below 30 ng/ml, vitamin D2 (ergocalciferol) replacement treatment is suggested (3).
Inflammation is an important risk factor in general public and patients with chronic kidney disease with respect to cardiovascular diseases and mortality (4,5). The uremia itself and the exposure of the blood to dialysate and dialysis membrane in the extracorporeal circulation during dialysis can stimulate the release of inflammatory cytokines (4). A significant relationship was observed between high CRP levels and increased mortality risk of hemodialysis patients (5). It was found that low hemoglobin levels in chronic kidney patients had negative effects on cardiovascular mortality, frequent admission to hospital, and left ventricular hypertrophy. Inflammation is also a proven risk factor that causes anemia for dialysis patients.
Vitamin D was found to inhibit antigenpresenting cell maturation, angiogenesis and vascular smooth muscle cell proliferation. Vitamin D has effect on up-regulation of nuclear factor-Kappa beta activity and IL-10, and down-regulation of IL-6, IL-12, IFN-γ and TNF-α. Due to these effects on cytokine profile Vit D is effective on reducing inflammation.
Hemodialysis adequacy is used in a broader sense today, covering all excretory and endocrine functions of kidney. However, it is traditionally defined as dialysis dose that is measured by solute removal. Methods such as single-pool Kt/V, urea reduction ratio are used to determine the dialysis adequacy for hemodialysis patients. As long as there is no significant residual renal function, it is suggested that dialysis should last at least 3 times per week and at least 12 hours. The target eKt/V is accepted as at least 1.2 for anuric patients, 1.4 for female and patients with comorbidity (6,7). The purpose of the present study is to find out whether there is a significant relationship between vitamin D levels and CRP, sedimentation rate, anemia, blood pressure levels and dialysis adequacy in hemodialysis patients.
MATERIAL AND METHODS:
Patients: 81 chronic hemodialysis patients were included in the study. The criteria for the inclusion to study are as follows: 1. Dialysis duration >3 months, 2. Not having an acute infection, clinically apparent heart and hepatic failure, acute coronary syndrome, cerebrovascular event, 3. Not having blood transfusion, 4. Not having a known malign disease or tuberculosis, 5. Fresenius 4008 S and 4008 B hemodialysis machines, standard heparinization and Fresenius high-flux dialyzer (150-190) with a synthetic polynephron structure and an effective surface area of 1.6-2.1m2 were used. All patients were dialyzed through arteriovenous fistulas with a blood flow > 300 ml/minute. The diet recommended for the patients included 1.2 gr/kg protein, 4 gr/NaCl, 2 gr potassium, 600 mg phosphorus, 1000 mg calcium. Also, oral B complex vitamin and levocarnitine 3 grams/week were used. Patients were treated with essential amino acid, oral phosphorus binders, active D vitamin (calcitriol) antihypertensive therapy and IV/subcutaneous erythropoietin according to results of monthly laboratory tests and clinical follow-up. The following formulas were used for KT calculations of Kt/V and residual kidney function.
Statistical Analysis: Statistical analyses were conducted by using SPSS (Statistical Package for Social Science) for Windows Version 10.0. Results were expressed as mean±SD. p<0.05 value was accepted as statistically significant.
RESULTS
The characteristics and laboratory parameters of the patients are summarized in table 1. It was found that 17,3% of our patients had severe vitamin D deficiency, 74,1% had moderate vitamin D deficiency, 6,2% had vitamin D deficiency, 2,5% had normal vit D levels. Female patients had lower vitamin D levels comparing to male patients (p=0,0001) A statistically significant negative correlation was found between Kt/V and vitamin D levels (p: -0,035). When diabetic patients were compared to non-diabetic patients, no statistically significant correlation was found between Kt/V level and vitamin D level in each group (p:0,377) (Figure 1) . No statistically significant ratio was found between vitamin D level and CRP, erythrocyte sedimentation rate and ferritin levels (p: 0,242, p: 0,564, p: 0,542 respectively) (Figure 2 ). CRP levels in diabetic patients was 0,84 mg/dl, while it was 0.7 ml/dl in non-diabetic patients. However, there was no statistically significant difference between diabetic group and non-diabetic group (p=0,528). It was also found that there was no statistically significant correlation between hemoglobin level and vitamin D level (p: 0,472). While a statistically significant relationship was found between serum vitamin D and serum Ca level (p: 0,048), no significant relationship were found with PTH and phosphorus levels (p: 0,555, p: 0,096). When vit D level and pre-and post-dialysis blood pressure levels were compared, it was found that there was no significant correlation. When blood pressure levels were compared between diabetic and non-diabetic patients, it was found that there was a statistically significant correlation between predialysis systolic blood pressure and vit D level in diabetic patients (p: 0.034). It was observed that there was no significant relationship between serum albumin level and vit D level (Table 2) .
DISCUSSION
The level of vitamin D in our patients was quite low as other studies. Only % 2.5 patients had normal vit D level. Also female patients comparing to male had significantly low vitamin D. Diabetic patients had no significantly lower levels according to nondiabetic patients. Taşkapan et al, in their study with 273 peritoneal dialysis (PD) patients in Turkey and Greece, reported that more than 95 % of the patients had low vitamin D level. It was found that our patients with normal vitamin D level were treated with vitamin D during non-dialysis period. Recently it has been shown that there is an improvement in morbidity and mortality in dialysis patients with high Kt/V values. It was seen that as the Kt/V value increases, morbidity and mortality rates significantly decreased (7,8). (9) . The mean Kt/V value of our patients were found to be 1,5±0,4. In our study it was found that a statistically significant negative correlation was found between Kt/V and vit D levels (p: -0,035). And also, when diabetic and nondiabetic patients were compared, no difference between the Kt/V levels was observed.
There are studies that show vitamin D is associated with several diseases and that regular vitamin D supplement has potential effects on improving various pathophysiological events. Zimmerman et al, stated that CRP and albumin were independent indicators for all causes of death in HD patients. Again, there are also studies stating that high inflammatory markers in uremic patients (especially IL-6 and hsCRP) are independent and strong pre-determiners for cardiovascular morbidity and mortality (10). The mean CRP and erythrocyte sedimentation rate were found to be increased. As inflammatory markers CRP and erythrocyte sedimentation rate were not correlated with vit D level.
Wong et al. (11) showed that PTH levels of CKD patients were dependent on 25(OH)D levels, and they drew a plateau when 25(OH)D levels were over 30 ng/ml. For this reason, it can be said that it reduces the risk of severe hyperparathyroidism when 25(OH)D level in the circulation is at least 30 ng/ml in CKD patients. It was observed that there was no significant correlation between vit D level and PTH level of our the patients Melamed et al. (12) , in a study they conducted with 13331 participants aged over 20, reported that as 25(OH)D3 levels decreased, mean systolic and diastolic blood pressure increased; mean body mass index, incidence of diabetes, proteinuria, serum C reactive protein level increased; and mean serum albumin levels decreased. Participants were monitored for an average of 8,7 years and in the group where vitamin D levels were found the lowest, mortality due to all reasons was found to increase 1.78 times. In our group of patients, no relationship was found between pre-and post-dialysis systolic/diastolic blood pressure levels and vit D.
Only statistically significant correlation was found between systolic blood pressure and vit D levels in our diabetic patients. Hemoglobin, serum albumin levels which determines dialysis adequacy, were also not correlated with vitamin D.
CONCLUSION
In conclusion, the 25OH vitamin D levels were found to be quite low in our hemodialysis patients when compared to the guideline suggestions. The 25 OH vit D level was found low in more than 95% of our hemodialysis patients. There was an inverse relationship between Kt/V and 25 OH vitamin D. This may due to the fact that the measurements were done in spring and that we measured 25 OH vitamin D level instead of serum 1-25 (OH)2 vitamin D. There were not any correlation between Vitamin D levels and inflammatuar markers including erythrocyte sedimentation rate, CRP and albumin and hemoglobin levels. So that it may be more appropriate measuring serum level of 1-25 (OH)2 vitamin D, to assess the vitamin D status of dialysis patients treated with calcitriol.
